Dengvaxia, crafted by Sanofi Pasteur, stands as the sole dengue vaccine sanctioned by the U.S. FDA. It's advised for regular use to guard against all four dengue virus types, thanks to the Advisory Committee on Immunization Practices. Approved since 2022!

Great news for dengue prevention! It's wonderful to see advancements in vaccine development. Public health is a top priority!

Absolutely! Vaccines play a crucial role in preventing the spread of infectious diseases like dengue. This progress is indeed a significant step towards enhancing public health outcomes.